metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P- 84 ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSY, IS IT READY FOR PRIMETIME?
Información de la revista
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Acceso a texto completo
P- 84 ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSY, IS IT READY FOR PRIMETIME?
Visitas
194
Daniela Hernández-Castro1, Wagner Ramírez-Quesada2, Carolina Gutiérrez-Ramírez2, Sylvia Álvarez-Umaña3, José Pablo Cortes-Navarrete2, Aldo Carvajal-González2, Francisco Hevia-Urrutia2, Ana Lorena Madrigal-Méndez2, Jorge Vargas-Madrigal2
1 Gastroenterology Department, México Hospital -University of Costa Rica, San José, Costa Rica
2 Gastroenterology Department, San Juan de Dios Hospital -University of Costa Rica, San José, Costa Rica
3 Gastroenterology Department, Hospital de Ciudad Neily-University of Costa Rica, San José, Costa Rica
Este artículo ha recibido
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 28. Núm S1

Abstracts of the 2022 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Endoscopic ultrasound-guided liver biopsy (EUS-LB) has been proposed as a novel technique that could offer some advantages over traditional methods, especially regarding specimen adequacy. A systematic review that included 32 studies evaluating the quality of percutaneous hepatic biopsies (PC-LB) demonstrated that the average number of portal tracts with this technique was 7.5 +/-3.4. (1) The objective of our study was to determine if EUS-LBs meet AASLD quality criteria, defined by the presence of more than 11 portal tracts.

Materials and Methods

A retrospective study was carried out from a prospectively created EUS-LB database. The primary objective was to evaluate the sample quality, using as a parameter the number of portal tracts. The secondary objective was to determine the security profile of the procedure and evaluate the rate of complications.

Results

82 patients were included (average age 55). The main indication for tissue acquisition was elevated transaminases. Steatosis/steatohepatitis was the most common histological diagnosis. The average number of portal tracts was 19.23 +/- 7.2. All the samples had at least 11 portal tracts. The rate of adverse events was 9.75%. The majority were minor complications (post-procedure pain). Only one patient presented a severe complication, bleeding secondary to an arterio-biliary fistula, that required embolization by interventional radiology.

Conclusions

EUS-LBs meet quality criteria established by AASLD, have an excellent security profile, and might be considered the method of choice for liver tissue acquisition in the centers where the resource is available.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos